Highlights
- •Subendothelial LDL-adhesion is a key event in the atherosclerotic lesion formation.
- •During oxidation aldehydes could leak out of the LDL-particle and modify nearby matrix proteins.
- •Aldehyde-collagen type IV correlated with oxidized LDL and was increased in symptomatic lesions.
- •Aldehyde-modification of collagen type IV decreased endothelial cell attachment.
- •Aldehyde-modification of collagen type IV may cause endothelial dysfunction and increase the risk of clinical events.
Abstract
Objective
Subendothelial LDL-adhesion and its subsequent oxidation are considered as key events
in the development of atherosclerotic lesions. During oxidation of LDL, reactive aldehydes
such as malondialdehyde (MDA) are formed, which modify apolipoprotein B100. However,
the possibility that these reactive aldehydes could leak out of the LDL-particle and
modify surrounding extracellular matrix proteins has been largely unexplored. We have
investigated if aldehyde-modification of collagen type IV, one of the major basement
membrane components, in plaques is associated with cardiovascular events.
Methods
The amount of MDA-modified collagen type IV and native collagen type IV were determined
in homogenates from 155 carotid artery lesions, removed by endarterectomy from patients
with or without previous cerebrovascular events.
Results
Plaque MDA-collagen type IV, but not native collagen type IV, correlated with oxidized
LDL (r = 0.31, P < 0.001) and lipoprotein-associated phospholipase A2 (r = 0.44, P < 0.001). MDA-collagen type IV was increased in lesions from symptomatic patients
compared to lesions from asymptomatic patients. Auto-antibodies against MDA-collagen
type IV in plasma correlated with the amount of MDA-collagen type IV in lesions. MDA-modification
of collagen type IV decreased endothelial cell attachment. In addition, culture of
endothelial cells with MDA-modified collagen type IV increased vascular cell adhesion
molecule expression and reduced the anti-coagulant proteins thrombomodulin and endothelial
protein C receptor. In the lesions native collagen type IV, but not MDA-collagen type
IV, was positively associated with thrombomodulin.
Conclusion
The present observations imply that aldehyde-modification of collagen type IV, associated
with LDL oxidation, in atherosclerotic plaques may cause endothelial dysfunction and
increase the risk of clinical events.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to AtherosclerosisAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Interaction of native and modified low-density lipoproteins with extracellular matrix.Curr. Opin. Lipidol. 2000; 11: 457-463
- Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis.Arterioscler. Thromb. Vasc. Biol. 2004; 24: 2211-2218
- Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.Circulation. 2007; 116: 1832-1844
- Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.Nature. 2002; 417: 750-754
- Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis.J. Intern. Med. 2000; 247: 371-380
- Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease.Curr. Pharm. Des. 2007; 13: 1021-1030
- Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.J. Intern. Med. 2009; 265: 593-603
- Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe−/− mice.Atherosclerosis. 2010; 212: 457-465
- The molecular mechanisms of the thrombotic complications of atherosclerosis.J. Intern. Med. 2008; 263: 517-527
- Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques.Stroke. 2003; 34: 616-622
- The clinical implications of endothelial dysfunction.J. Am. Coll. Cardiol. 2003; 42: 1149-1160
- Decreased nitric oxide synthesis in human endothelial cells cultured on type I collagen.Circ. Res. 2002; 90: 539-545
- Endothelium–role in regulation of coagulation and inflammation.Semin. Immunopathol. 2012; 34: 93-106
- Role of laminin terminal globular domains in basement membrane assembly.J. Biol. Chem. 2007; 282: 21437-21447
- Supramolecular assembly of basement membranes.Bioessays. 1996; 18: 123-132
- Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies.Arterioscler. Thromb. 1992; 12: 494-502
- The alpha 1 beta 1 integrin recognition site of the basement membrane collagen molecule [alpha 1(IV)]2 alpha 2(IV).EMBO J. 1993; 12: 4795-4802
- Structural basis of collagen recognition by integrin alpha2beta1.Cell. 2000; 101: 47-56
- Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification.Diabetes. 2006; 55: 1961-1969
- In vitro interactions of oxidatively modified LDL with type I, II, III, IV, and V collagen, laminin, fibronectin, and poly-D-lysine.Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2721-2728
- Low density lipoproteins bind more to type I and III collagens by negative charge-dependent mechanisms than to type IV and V collagens.Atherosclerosis. 1994; 107: 109-116
- Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.Circ. Res. 2008; 103: 43-52
- Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core.Eur. J. Biochem. 1992; 208: 359-366
- Collagen synthesis in atherosclerosis: too much and not enough.Cardiovasc. Res. 1999; 41: 376-384
- Increased glycoxidation and lipoperoxidation in the collagen of the myocardium in hemodialysis patients.Cardiovasc. Res. 2000; 47: 306-313
- Possible involvement of increased glycoxidation and lipid peroxidation of elastin in atherogenesis in haemodialysis patients.Nephrol. Dial. Transplant. 2002; 17: 630-636
- Reactions of lipid-derived malondialdehyde with collagen.J. Biol. Chem. 1999; 274: 19661-19669
- The importance of lipid-derived malondialdehyde in diabetes mellitus.Diabetologia. 2000; 43: 550-557
Article info
Publication history
Published online: February 24, 2015
Accepted:
February 22,
2015
Received in revised form:
February 13,
2015
Received:
October 29,
2014
Identification
Copyright
© 2015 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.